Kiora Pharmaceuticals EVP Keith J. Lane files initial beneficial ownership statement
Kiora Pharmaceuticals filed an initial beneficial ownership statement for Keith J. Lane, EVP of Clinical and Regulatory. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated conten